We now have a lower threshold to meet the U.S
[1] [3] If left untreated, some of these changes can become permanent
Clinical research The foundational characterization of GHK-Cu as a growth-modulating plasma tripeptide that functions by facilitating copper uptake into cells was published in Nature by Pickart et al

Benefits AOD-9604 is believed to help with: Mechanistically designed to support fat breakdown and reduce new fat formation while having minimal direct impact on blood sugar and IGF1. May offer modest additional help with fat metabolism when combined with calorie control and exercise, particularly in higheradiposity individuals. Typically administered as a daily subcutaneous injection in low doses, integrated into a broader metabolic and lifestyle protocol. Longterm clinical safety data show generally good tolerability in studied populations, but regulators have highlighted unresolved immunogenicity and impurity concerns, so usage must remain cautious and fully consented. Positioned as an optional, supportive layernot a standalone weight-loss solutionwith emphasis on lab monitoring, habit coaching, and realistic expectations.
Good sources: animal proteins (chicken, fish, eggs, beef), Greek yogurt, cottage cheese, whey or collagen protein supplements
That's a fundamentally different proposition from administering a synthetic analog